Two Blades Foundation

The partners will investigate new sources of potato infections, including late blight and test new genes for their ability to confer disease resistance.

The money will be distributed to research groups studying the mechanisms by which three major agricultural plant systems resist infection by pathogens.

The arrangement covers Cellectis' TALEN technology and Two Blades' TAL effector code technology.

NEW YORK (GenomeWeb News) – DuPont Pioneer and the Two Blades Foundation today announced a research collaboration to develop soybean varieties with greater resistance to Asian Soybean Rust.

NEW YORK (GenomeWeb News) – The Two Blades Foundation today announced a licensing agreement with Dupont Pioneer providing it access to 2Blades' TAL Code technology for commercial use in certain crop plants.

NEW YORK (GenomeWeb News) – The Two Blades Foundation and Monsanto today announced an expansion of their agreement to provide Monsanto additional TAL Code technologies.

NEW YORK (GenomeWeb News) – The Two Blades Foundation today said it has completed a non-exclusive licensing agreement with KWS SAAT covering Two Blades' Transcription Activator Like effector code technology for genome engineering in certain crops.

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific this week said that it has acquired Doe & Ingalls Management, a provider of production chemicals and customized supply chain services to the life sciences and microelectonic industries, for approximately $175 million in cash.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – The Two Blades Foundation said on Monday that it has licensed the TAL Code technology to Monsanto on a non-exclusive basis.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – The Two Blades Foundation has granted Syngenta access to its genome engineering technology for commercial uses in certain crop plants under an agreement announced late on Tuesday.

Pages

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.